España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
VYNE Therapeutics
VYNE
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$2.50
0.11
4.60%
At close: -
$2.39
-0.11
-4.40%
After Hours: Dec 19, 4:09 PM EDT
Get Report
Comment
VYNE Therapeutics (VYNE) Forecast
News
Earnings
VYNE Therapeutics (VYNE) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for VYNE Therapeutics (NASDAQ:VYNE) Stock
VYNE Therapeutics Stock (NASDAQ: VYNE)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, November 18, 2024
BTIG Initiates Coverage On VYNE Therapeutics ...
Benzinga Newsdesk
Friday, November 08, 2024
HC Wainwright & Co. Reiterates Buy on VYNE Th...
Benzinga Newsdesk
Thursday, November 07, 2024
VYNE Therapeutics Q3 2024 GAAP EPS $(0.29) Mi...
Benzinga Newsdesk
VYNE Therapeutics Q3 EPS $(0.29) Misses $(0.2...
Benzinga Newsdesk
Thursday, September 12, 2024
HC Wainwright & Co. Reiterates Buy on VYNE Th...
Benzinga Newsdesk
VYNE Therapeutics Announces Phase 1a SAD Data...
Benzinga Newsdesk
Thursday, August 15, 2024
HC Wainwright & Co. Reiterates Buy on VYNE Th...
Benzinga Newsdesk
Wednesday, August 14, 2024
VYNE Therapeutics Q2 2024 GAAP EPS $(0.22) Mi...
Benzinga Newsdesk
Tuesday, July 16, 2024
VYNE Therapeutics Announces Composition Of Ma...
Benzinga Newsdesk
Thursday, June 20, 2024
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Friday, June 14, 2024
Analyst Scoreboard: 4 Ratings For VYNE Therapeutics
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on VYNE Th...
Benzinga Newsdesk
Thursday, June 13, 2024
VYNE Therapeutics Doses First Volunteers In P...
Benzinga Newsdesk
Wednesday, June 05, 2024
HC Wainwright & Co. Reiterates Buy on VYNE Th...
Benzinga Newsdesk
VYNE Therapeutics Doses First Subject In Phas...
Benzinga Newsdesk
Thursday, May 09, 2024
HC Wainwright & Co. Reiterates Buy on VYNE Th...
Benzinga Newsdesk
VYNE Therapeutics Q1 EPS $(0.15) Beats $(0.24...
Benzinga Newsdesk
Monday, May 06, 2024
HC Wainwright & Co. Reiterates Buy on VYNE Th...
Benzinga Newsdesk
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
VYNE Therapeutics Announces FDA Clearance Of ...
Benzinga Newsdesk
Wednesday, May 01, 2024
VYNE Therapeutics Presents VYN201 At 2024 SID...
Benzinga Newsdesk
Friday, March 29, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Thursday, February 29, 2024
HC Wainwright & Co. Reiterates Buy on VYNE Th...
Benzinga Newsdesk
Recap: VYNE Therapeutics Q4 Earnings
Benzinga Insights
VYNE Therapeutics Ended 2023 With $93.3M Of C...
Benzinga Newsdesk
VYNE Therapeutics Q4 Adjusted EPS $(0.18) Bea...
Benzinga Newsdesk
Tuesday, February 27, 2024
VYNE Therapeutics To Present Results Of Phase...
Benzinga Newsdesk
Tuesday, January 16, 2024
Top 4 Health Care Stocks That May Rocket Higher In Q1
Avi Kapoor
Thursday, January 11, 2024
Why Richardson Electronics Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Wednesday, January 10, 2024
VYNE Therapeutics Announces Biomarker Data Fr...
Benzinga Newsdesk
Monday, November 13, 2023
VYNE Therapeutics Q3 Adj EPS $(1.59) Beats $(...
Benzinga Newsdesk
Recap: VYNE Therapeutics Q3 Earnings
Benzinga Insights
Monday, October 30, 2023
Dow Surges Over 500 Points; Western Digital Announces Plan To Split Into Two Companies
Lisa Levin
HC Wainwright & Co. Maintains Buy on VYNE The...
Benzinga Newsdesk
Why ON Semiconductor Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Positive Momentum For VYNE Therapeutics' Psoriasis, Rheumatoid Arthritis Candidate - Analyst Expresses Encouragement
Vandana Singh
Crude Oil Falls Over 3%; Miromatrix Medical Shares Spike Higher
Lisa Levin
Why Vyne Therapeutics Stock Is Climbing
Erica Kollmann
Nasdaq Gains Over 1%; McDonald's Reports Upbeat Earnings
Lisa Levin
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Market-Moving News for October 30th
Benzinga Newsdesk
VYNE Therapeutics shares are trading higher a...
Benzinga Newsdesk
VYNE Therapeutics Reports Private Placement O...
Benzinga Newsdesk
VYNE Therapeutics Announces Data from Phase 1...
Benzinga Newsdesk
Tuesday, September 26, 2023
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Monday, August 14, 2023
HC Wainwright & Co. Reiterates Buy on VYNE Th...
Benzinga Newsdesk
VYNE Therapeutics Q2 EPS $(3.09) Misses $(1.99) Estimate, Sales $135.00K Beat $100.00K Estimate
Happy Mohamed
Friday, May 12, 2023
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Why Heron Therapeutics Shares Are Trading Lower By 34%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch